BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16357945)

  • 1. Development of a miniaturized assay for the high-throughput screening program for poly(ADP-ribose) polymerase-1.
    Lee S; Koo HN; Lee BH
    Methods Find Exp Clin Pharmacol; 2005 Nov; 27(9):617-22. PubMed ID: 16357945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a high-throughput screening-amenable assay for human poly(ADP-ribose) polymerase inhibitors.
    Brown JA; Marala RB
    J Pharmacol Toxicol Methods; 2002; 47(3):137-41. PubMed ID: 12628304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors.
    Putt KS; Hergenrother PJ
    Anal Biochem; 2004 Mar; 326(1):78-86. PubMed ID: 14769338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A scintillation proximity assay for poly(ADP-ribose) polymerase.
    Cheung A; Zhang J
    Anal Biochem; 2000 Jun; 282(1):24-8. PubMed ID: 10860495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations.
    Geraets L; Moonen HJ; Wouters EF; Bast A; Hageman GJ
    Biochem Pharmacol; 2006 Sep; 72(7):902-10. PubMed ID: 16870158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of high-throughput screening assays for poly(ADP-ribose) polymerase-2 inhibitors.
    Zhu Z; Jin J; Xue N; Song X; Chen X
    Anal Biochem; 2014 Mar; 449():188-94. PubMed ID: 24382396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
    Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A FlashPlate assay for the identification of PARP-1 inhibitors.
    Dillon KJ; Smith GC; Martin NM
    J Biomol Screen; 2003 Jun; 8(3):347-52. PubMed ID: 12857389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase.
    Menear KA; Adcock C; Alonso FC; Blackburn K; Copsey L; Drzewiecki J; Fundo A; Le Gall A; Gomez S; Javaid H; Lence CF; Martin NM; Mydlowski C; Smith GC
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3942-5. PubMed ID: 18579376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Simple, Sensitive, and Generalizable Plate Assay for Screening PARP Inhibitors.
    Kirby IT; Morgan RK; Cohen MS
    Methods Mol Biol; 2018; 1813():245-252. PubMed ID: 30097873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-ribose) polymerase-1 protects excessive DNA strand breaks from deterioration during repair in human cell extracts.
    Parsons JL; Dianova II; Allinson SL; Dianov GL
    FEBS J; 2005 Apr; 272(8):2012-21. PubMed ID: 15819892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Throughput Colorimetric Assay for Identifying PARP-1 Inhibitors Using a Large Small-Molecule Collection.
    Kotova E; Tulin AV
    Methods Mol Biol; 2017; 1608():299-312. PubMed ID: 28695517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast.
    Perkins E; Sun D; Nguyen A; Tulac S; Francesco M; Tavana H; Nguyen H; Tugendreich S; Barthmaier P; Couto J; Yeh E; Thode S; Jarnagin K; Jain A; Morgans D; Melese T
    Cancer Res; 2001 May; 61(10):4175-83. PubMed ID: 11358842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improved nonisotopic test to screen a large series of new inhibitor molecules of poly(ADP-ribose) polymerase activity for therapeutic applications.
    Decker P; Miranda EA; de Murcia G; Muller S
    Clin Cancer Res; 1999 May; 5(5):1169-72. PubMed ID: 10353753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel PARP-1 inhibitors by structure-based virtual screening.
    Hannigan K; Kulkarni SS; Bdzhola VG; Golub AG; Yarmoluk SM; Talele TT
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5790-4. PubMed ID: 24074844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces oxidative stress, DNA strand breaks, and poly(ADP-ribose) polymerase-1 activation in human breast carcinoma cell lines.
    Lin PH; Lin CH; Huang CC; Chuang MC; Lin P
    Toxicol Lett; 2007 Aug; 172(3):146-58. PubMed ID: 17669606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ADP-ribose) polymerase inhibitors.
    Southan GJ; Szabó C
    Curr Med Chem; 2003 Feb; 10(4):321-40. PubMed ID: 12570705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of ROS formation, poly(ADP-ribose) polymerase-1 activation, and cell death by PCB126 and PCB153 in human T47D and MDA-MB-231 breast cancer cells.
    Lin CH; Lin PH
    Chem Biol Interact; 2006 Aug; 162(2):181-94. PubMed ID: 16884709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAD+ as a metabolic link between DNA damage and cell death.
    Ying W; Alano CC; Garnier P; Swanson RA
    J Neurosci Res; 2005 Jan 1-15; 79(1-2):216-23. PubMed ID: 15562437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PARP inhibitors for cancer therapy.
    Curtin NJ
    Expert Rev Mol Med; 2005 Mar; 7(4):1-20. PubMed ID: 15836799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.